Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes

This study has been terminated.
(Durability of study medications could not be guaranteed after the expire date.)
Sponsor:
Information provided by (Responsible Party):
Kaj Stenlof, Vastra Gotaland Region
ClinicalTrials.gov Identifier:
NCT01238224
First received: October 6, 2010
Last updated: June 18, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)